Literature DB >> 12646630

SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production.

Tomonori Ishii1, Kei Ohnuma, Akikazu Murakami, Naruhiko Takasawa, Tadanori Yamochi, Satoshi Iwata, Masahiko Uchiyama, Nam H Dang, Hirotoshi Tanaka, Chikao Morimoto.   

Abstract

An autoantibody against SS-A/Ro52 (Ro52) is most frequently found in the sera of patients with Sjögren's syndrome, systemic lupus erythematosus, and congenital heart block from anti-Ro52 Ab-positive mother. However, the physiological function of the autoantigen SS-A/Ro52 has not yet been elucidated. In this study, we describe the role of Ro52 protein in T cell activation. Overexpression of SS-A/Ro52 in Jurkat T cell resulted in enhanced IL-2 production following CD28 stimulation. Furthermore, transfection of anti-Ro52-specific small RNA duplexes partially blocked the expression of native and overexpressed Ro52 in Jurkat T cell, resulting in decreased IL-2 production via CD28 pathway in these cells. Finally, intracellular localization of Ro52 dramatically changed following CD28 stimulation. Our data reveal a novel function of Ro52 in CD28-mediated pathway, which eventually contributes to cytokine production and expression of the T cell biological programs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646630     DOI: 10.4049/jimmunol.170.7.3653

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.

Authors:  Ryusuke Yoshimi; Tsung-Hsien Chang; Hongsheng Wang; Toru Atsumi; Herbert C Morse; Keiko Ozato
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity.

Authors:  Yun Kyoung Kang; Sung Yun Jung; Jun Qin; Chao Li; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

3.  Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.

Authors:  Abdelmajid Sabile; Andrea Michael Meyer; Christiane Wirbelauer; Daniel Hess; Ulrike Kogel; Martin Scheffner; Wilhelm Krek
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 4.  The cell biology of TRIM5α.

Authors:  Zana Lukic; Edward M Campbell
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

5.  Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.

Authors:  Qianshan Ding; Du He; Ke He; Qian Zhang; Meng Tang; Jinfen Dai; Hanlin Lv; Xiaochen Wang; Guoan Xiang; Honggang Yu
Journal:  Tumour Biol       Date:  2015-06-09

6.  [TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting β-catenin ubiquitylation and degradation].

Authors:  Z Zhang; Z Zhu; H Sheng; J Sun; C Cao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

7.  CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.

Authors:  Kei Ohnuma; Tadanori Yamochi; Masahiko Uchiyama; Kunika Nishibashi; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Hirotoshi Tanaka; Nam H Dang; Chikao Morimoto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 8.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

9.  The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3.

Authors:  Rowan Higgs; Joan Ní Gabhann; Nadia Ben Larbi; Eamon P Breen; Katherine A Fitzgerald; Caroline A Jefferies
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

10.  TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation.

Authors:  Birte Zurek; Ida Schoultz; Andreas Neerincx; Luisa M Napolitano; Katharina Birkner; Eveline Bennek; Gernot Sellge; Maria Lerm; Germana Meroni; Johan D Söderholm; Thomas A Kufer
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.